IP Library Granted Patent US 8,577,478
Granted Patent B2
US 8,577,478 · App. 13/629,725 · Granted Nov 5, 2013

Antenna providing variable communication with an implant

Inventors: Adi Mashiach (Mont-St-Guibert, BE); Carsten Mueller (St. Ingbert, DE)
Assignee: Nyxoah SA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,577,478
App. No.
13/629,725
Granted
Nov 5, 2013
Kind
B2
Abstract

A device may include a primary antenna configured to be located external to a subject and at least one processor in electrical communication with the primary antenna. The at least one processor may be configured to cause transmission of a primary signal from the primary antenna to an implantable device, wherein the implantable device includes at least one pair of modulation electrodes. The at least one processor may be further configured to adjust one or more characteristics of the primary signal to generate a sub-modulation control signal adapted so as not to cause a neuromuscular modulation inducing current at the at least one pair of modulation electrodes when received by the implantable device and to generate a modulation control signal adapted so as to cause a neuromuscular modulation inducing current at the at least one pair of modulation electrodes when received by the implantable device.

Claims (17)

1. A sleep apnea treatment device, comprising:

a primary antenna configured to be located external to a subject,

at least one processor in electrical communication with the primary antenna, the

at least one processor configured to:

cause transmission of a primary signal from the primary antenna to an implantable device implanted in the subject on a genioglossus muscle proximal to a hypoglossal nerve of the subject, wherein the implantable device includes at least one pair of modulation electrodes,

wherein the processor is further configured to adjust one or more characteristics of the primary signal to generate a sub-modulation control signal adapted to cause a current at the at least one pair of modulation electrodes below a neuromuscular modulation threshold of the hypoglossal nerve when received by the implantable device and to generate a modulation control signal adapted to cause a current at the at least one pair of modulation electrodes above a neuromuscular modulation threshold of the hypoglossal nerve when received by the implantable device.

2. The sleep apnea treatment device of claim 1 , wherein the at least one processor is further configured to receive via the primary antenna, a condition signal from an implantable device in response to the sub-modulation control signal.

3. The sleep apnea treatment device of claim 2 , wherein the condition signal is indicative of at least one of a movement of the implantable device, a location of the implantable device, a maximum power limit of the implantable device, and a minimum efficacy threshold of the device.

4. The sleep apnea treatment device of claim 2 , wherein the condition signal is indicative of tongue movement.

5. The sleep apnea treatment device of claim 1 , wherein the one or more adjusted characteristics of the primary signal include at least one of a voltage, current, frequency, pulse rate, pulse width, and duration.

6. The sleep apnea treatment device of claim 2 , wherein transmission of the primary signal is triggered by the condition signal indicative of a predetermined amount of movement of the implantable device.

7. The sleep apnea treatment device of claim 2 , wherein movement of the implantable device is indicative of an amount of tongue movement associated with sleep disordered breathing and the amount of tongue movement is indicative of a severity of the sleep disordered breathing.

8. The sleep apnea treatment device of claim 2 , wherein the condition signal is indicative of a degree of coupling between the primary antenna and a secondary antenna associated with the implantable device, the degree of coupling relating to at least one of a level of radiofrequency coupling, a level of inductive coupling.

9. The sleep apnea treatment device of claim 1 , wherein the primary antenna is flexible to an extent permitting it to generally conform to the contours of a subject's skin.

10. The sleep apnea treatment device of claim 1 , the primary antenna and at least one processor are located on a patch configured to be removably affixed to the skin of a subject.

11. The sleep apnea treatment device of claim 2 , wherein the processor is further configured to adjust the one or more characteristics of the primary signal so as to elicit the condition signal from the implantable device.

12. The sleep apnea treatment device of claim 2 , wherein the processor is further configured to adjust the one or more characteristics of the primary signal based on the condition signal from the implantable device.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2018
From: MASHIACH, ADI
To: NYXOAH SA
Reel/Frame 047125/0197 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER LISTED ON THE COVERSHEET FROM 13629726 TO 13629725 IN THE ASSIGNMENT PREVIOUSLY RECORDED ON REEL 030515 FRAME 0316. ASSIGNOR(S) HEREBY CONFIRMS THE CONVEYANCE OF APPLICATION 13629725.. Recorded Jun 4, 2013
From: MASHIACH, ADI; MUELLER, CARSTEN
To: NYXOAH SA
Reel/Frame 030547/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2013
From: MASHIACH, ADI, DR; MUELLER, CARSTEN
To: NYXOAH SA
Reel/Frame 030515/0316 →
Continuity (3)
Provisional Application 61541651 · Sep 30, 2011
Provisional Application 61657424 · Jun 8, 2012
Related Publication 20130085540A1 · Apr 4, 2013